» Articles » PMID: 16455317

Osteoporosis: a Still Increasing Prevalence

Overview
Journal Bone
Date 2006 Feb 4
PMID 16455317
Citations 361
Authors
Affiliations
Soon will be listed here.
Abstract

It is estimated that over 200 million people worldwide have osteoporosis. The prevalence of osteoporosis is continuing to escalate with the increasingly elderly population. The major complication of osteoporosis is an increase in fragility fractures leading to morbidity, mortality, and decreased quality of life. In the European Union, in 2000, the number of osteoporotic fractures was estimated at 3.79 million. A baseline fracture is a very strong predictor of further fractures with 20% of patients experiencing a second fracture within the first year. The costs to health care services are already considerable and, on current trends, are predicted to double by 2050. The direct costs of osteoporotic fractures to the health services in the European Union in the year 2000 were estimated at 32 billion Euros. Guidelines for the diagnosis and treatment of osteoporosis are available in many countries; however, implementation is generally poor despite the availability of treatments with proven efficacy. Programs to increase awareness of osteoporosis and its outcomes are necessary for healthcare specialists and the general public. Earlier diagnosis and intervention prior to the first fracture are highly desirable.

Citing Articles

Association between serum uric acid levels and bone mineral density in Chinese and American: a cross-sectional study.

Li X, Peng Y, Chen K, Zhou Y, Luo W Sci Rep. 2025; 15(1):8304.

PMID: 40064963 PMC: 11894223. DOI: 10.1038/s41598-025-92348-3.


Risk of adverse cardiovascular events following spinal cord injury in patients with osteoporosis: Real-world evidence.

Kao S, Yu Y, Tsai M Am J Prev Cardiol. 2025; 21:100938.

PMID: 39995848 PMC: 11847749. DOI: 10.1016/j.ajpc.2025.100938.


Landscape analysis of m6A modification reveals the dysfunction of bone metabolism in osteoporosis mice.

Zheng L, Lan C, Gao X, Zhu A, Chen Y, Lin J Heliyon. 2025; 11(3):e42123.

PMID: 39991256 PMC: 11847259. DOI: 10.1016/j.heliyon.2025.e42123.


Unexpected Increase in Bone Mineral Density With Rapamycin and Low-Dose Naltrexone: A Case Report of a 52-Year-Old Woman With Osteopenia.

Britton A, Harinath G, Morgan S, Zalzala S Cureus. 2025; 17(1):e77435.

PMID: 39958011 PMC: 11825221. DOI: 10.7759/cureus.77435.


Causal associations between osteoporosis and HBV infection across Asian and European populations: evidence from Mendelian randomization and colocalization analysis.

Li Z, Cao J, Li K, Wu Y, Luo Z, Cao R Front Endocrinol (Lausanne). 2025; 15:1419303.

PMID: 39911237 PMC: 11794126. DOI: 10.3389/fendo.2024.1419303.